The 4 Ps Screening Tool for Pregnancy
The 4 Ps is a brief substance use screening tool developed by Hope Ewing in 1990 that asks pregnant women about four key risk domains: Parents, Peers, Partner, and Past substance use, with a fifth question added about substance use during Pregnancy (making it the "4Ps Plus" or "5Ps") 1.
The Five Questions
The 4Ps Plus screening questions are 1:
- Parents: Did either of your parents have a problem with alcohol or drug use?
- Peers: Do any of your friends have a problem with alcohol or other drug use?
- Partner: Does your partner have a problem with alcohol or drugs?
- Past: Have you ever drunk alcohol?
- Pregnancy: In the month before you knew you were pregnant:
- How many cigarettes did you smoke?
- How much wine/beer/liquor did you drink?
- How much marijuana did you smoke?
- How much medication for pain, anxiety, or depression (such as Vicodin, Valium, or Oxycontin) did you take?
Performance Characteristics
The 4Ps Plus demonstrates reasonable screening performance with sensitivity of 87%, specificity of 76%, positive predictive value of 36%, and negative predictive value of 97% 1. This means it correctly identifies substance use status 78% of the time when compared to clinical interviews 1.
Important Caveats
- The 4Ps Plus is copyrighted and available only for a fee from NTI Publishing 1
- A free alternative exists: the 5Ps Prenatal Substance Abuse Screen adapted by the Massachusetts Institute for Health and Recovery, which uses slightly different wording but similar content 1
- The 5Ps version is widely used in Massachusetts, California, Maine, Virginia, and South Carolina but has not undergone rigorous validation studies 1
- Neither version has been validated against biological measures (urine/hair toxicology) 1
Clinical Recommendation
The 4Ps/5Ps is recommended as one of the preferred screening tools for substance use in pregnancy due to its public availability (5Ps version), ease of use, and brevity 1. The joint SMFM/ACOG/ASAM guideline specifically states that "the public availability and ease of use of the NIDA Quick Screen, 4Ps, and CRAFFT argue for their preference" until further research identifies a clearly superior tool 1.
Follow-Up After Positive Screen
When screening is positive 1:
- Conduct a nonjudgmental follow-up conversation reviewing results and current substance use patterns
- Avoid stigmatizing terms like "addict"
- Discuss local laws regarding mandatory reporting and custody implications
- Offer information about treatment resources and emphasize that substance use disorder is treatable during pregnancy
- For opioid use disorder, facilitate prompt referral for medication-assisted treatment (MAT) with buprenorphine or methadone